Sino Biopharmaceutical | 1177 - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Moderna USD 603M 7M 2026-03
Organon & Co USD 8.55B 75M 2026-03
Revvity USD 2.63B 836K 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.41B 67.1M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03